Floatz logo

LENVATINIB

Liver Transplant

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySmall moleculePhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Liver Transplant cohort.

Asset / SponsorPhaseRating
TACROLIMUS
University of Illinois at Chicago
Phase 4BBB
CYCLOSPORIN A
Fernanda P Silveira, MD, MS
Phase 4BBB
Rapamycin
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4BBB
Busulphan
M.D. Anderson Cancer Center
Phase 3BB
Fludarabine
M.D. Anderson Cancer Center
Phase 3BB

View all 33 →

Same molecule, other indications

LENVATINIB is also rated in:

Primary Peritoneal Cavity CancerDormant
BBB
Indicative ·
73 / 100
View asset →
Stage IIB Breast CancerDormant
BBB
Indicative ·
73 / 100
View asset →
portal vein thrombosisDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →